TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis

TCT-478 New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis

Low molecular weight heparins ( LMWH) are considered the standard of care due to their superiority over warfarin. New oral anticoagulants (NOAC) are promising drugs which can simplify long term care of cancer patients with DVT.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-09, Vol.64 (11), p.B140-B141
Hauptverfasser: Sharifi, Mohsen, Freeman, Wilbur K, Camiliere, Taylor M, Vajo, Zoltan, Bay, Curt, Sharifi, Mirali, Schwartz, Frederic
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cancer
Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Mortality
Patient satisfaction
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Low molecular weight heparins ( LMWH) are considered the standard of care due to their superiority over warfarin. New oral anticoagulants (NOAC) are promising drugs which can simplify long term care of cancer patients with DVT.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.07.532